メフロキン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "メフロキン" in Japanese language version.

refsWebsite

Global rank Japanese rank

24nih.gov

4^th place

24^th place

14doi.org

2^nd place

6^th place

4rochecanada.com

low place

3wikipedia.org

low place

3fda.gov

447^th place

1,043^rd place

3va.gov

4,581^st place

low place

2drugs.com

399^th place

1,603^rd place

2sciencedirect.com

149^th place

558^th place

2cdc.gov

218^th place

712^th place

2bmj.com

1,226^th place

1,988^th place

1google.ca

838^th place

1,403^rd place

1who.int

195^th place

376^th place

1lci.fr

2,800^th place

low place

1idsociety.org

low place

1pmda.go.jp

6,690^th place

394^th place

1biomedcentral.com

2,747^th place

2,369^th place

1theglobeandmail.com

293^rd place

1,518^th place

1jcp.or.jp

5,229^th place

326^th place

1web.archive.org

1^st place

1pri.org

4,244^th place

low place

1espacenet.com

800^th place

2,213^th place

1aspetjournals.org

6,663^rd place

low place

aspetjournals.org

jpet.aspetjournals.org

Zhou C, Xiao C, McArdle JJ, Ye JH (February 2006). “Mefloquine enhances nigral gamma-aminobutyric acid release via inhibition of cholinesterase”. JPET 317 (3): 1155–1160. doi:10.1124/jpet.2005.106.101923. PMID 16501066.

biomedcentral.com

bmcpharmacoltoxicol.biomedcentral.com

Thomas KH (2014-09-30). “Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011.”. BMC Pharmacology and Toxicology 15 (54). doi:10.1186/2050-6511-15-54. PMC 4184159. PMID 25266008.

bmj.com

Bob Burton. (2004-11-06). “Australian army faces legal action over mefloquine.”. ブリティッシュ・メディカル・ジャーナル. (BMJ). 329 (7474): 1062. doi:10.1136/bmj.329.7474.1062-b. PMC 526142. PMID 15528599.

jnnp.bmj.com

Gofton TE, Al-Khotani1 A, O'Farrell B, Ang LC, McLachlan RS (June 2010). “Mefloquine in the treatment of progressive multifocal leukoencephalopathy”. J Neurol Neurosurg Psychiatry 82 (4): 452–455. doi:10.1136/jnnp.2009.190652. PMID 20562463.

cdc.gov

wwwnc.cdc.gov

“www.idsociety.org” (PDF). 2016年4月2日閲覧。 “Malaria - Chapter 3 - 2014 Yellow Book | Travelers' Health | CDC”. 2016年4月2日閲覧。

cdc.gov

“www.cdc.gov” (PDF). 2016年4月2日閲覧。

doi.org

Croft, AM (2007). “A lesson learnt: the rise and fall of Lariam and Halfan”. J R Soc Med. 4 (4): 170–4. doi:10.1258/jrsm.100.4.170. PMC 1847738. PMID 17404338.
Schlagenhauf, P; Adamcova, M; Regep, L; Schaerer, MT; Rhein, HG (2010-12-09). “The position of mefloquine as a 21st century malaria chemoprophylaxis”. Malaria journal 9: 357. doi:10.1186/1475-2875-9-357. PMC 3224336. PMID 21143906.
Schlagenhauf, P. (1999). “Mefloquine for malaria chemoprophylaxis 1992-1998”. Travel Med 6 (2): 122–123. doi:10.1111/j.1708-8305.1999.tb00843.x. PMID 10381965.
Jacquerioz, FA; Croft, AM (2009-10-07). Jacquerioz, Frederique A. ed. “Drugs for preventing malaria in travellers”. Cochrane database of systematic reviews (Online) (4): CD006491. doi:10.1002/14651858.CD006491.pub2. PMID 19821371.
González R, Hellgren U, Greenwood B, Menéndez C (2014). “Mefloquine safety and tolerability in pregnancy: a systematic literature review”. Malar. J. 13: 75. doi:10.1186/1475-2875-13-75. PMC 3942617. PMID 24581338.
Schlagenhauf P, Blumentals WA, Suter P, etal (2012). “Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy”. Clin Infect Dis 54 (11): e124–31. doi:10.1093/cid/cis215. PMC 3348951. PMID 22495078.
AlKadi, HO (2007). “Antimalarial drug toxicity: a review”. Chemotherapy 53 (6): 385-91. doi:10.1159/000109767. PMID 17934257.
Thomas KH (2014-09-30). “Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011.”. BMC Pharmacology and Toxicology 15 (54). doi:10.1186/2050-6511-15-54. PMC 4184159. PMID 25266008.
Bob Burton. (2004-11-06). “Australian army faces legal action over mefloquine.”. ブリティッシュ・メディカル・ジャーナル. (BMJ). 329 (7474): 1062. doi:10.1136/bmj.329.7474.1062-b. PMC 526142. PMID 15528599.
“Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study”. Clin. Infect. Dis. 33 (7): 1015–21. (October 2001). doi:10.1086/322694. PMID 11528574.
Gofton TE, Al-Khotani1 A, O'Farrell B, Ang LC, McLachlan RS (June 2010). “Mefloquine in the treatment of progressive multifocal leukoencephalopathy”. J Neurol Neurosurg Psychiatry 82 (4): 452–455. doi:10.1136/jnnp.2009.190652. PMID 20562463.
McArdle JJ, Sellin LC, Coakley KM, Potian JG, Quinones-Lopez MC, Rosenfeld CA, Sutatos LG, Hognason K (June 2005). “Mefloquine inhibits cholinesterases at the mouse neuromuscular junction”. Neuropharmacology 49 (8): 1132–1139. doi:10.1016/j.neuropharm.2005.06.011. PMID 16081111.
McArdle JJ, Sellin LC, Coakley KM, Potian JG, Hognason K (September 2006). “Mefloquine selectively increases asynchronous acetylcholine release from motor nerve terminals”. Neuropharmacology 50 (3): 345–353. doi:10.1016/j.neuropharm.2005.09.011. PMID 16288931.
Zhou C, Xiao C, McArdle JJ, Ye JH (February 2006). “Mefloquine enhances nigral gamma-aminobutyric acid release via inhibition of cholinesterase”. JPET 317 (3): 1155–1160. doi:10.1124/jpet.2005.106.101923. PMID 16501066.

drugs.com

“Lariam”. The American Society of Health-System Pharmacists. 2015年11月27日閲覧。
“Lariam”. The American Society of Health-System Pharmacists. 2011年4月3日閲覧。

espacenet.com

worldwide.espacenet.com

Fletcher, A., and Shepherd, R. Use of (+)-mefloquine for the treatment of malaria. US 6664397 .

fda.gov

accessdata.fda.gov

“Lariam medication guide”. Hoffman La Roche. 2013年9月27日閲覧。
“Label: Mefloquine Hydrochloride Tablets, USP” (pdf). 2016年10月21日閲覧。

fda.gov

“FDA Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects.” (pdf). 2016年10月21日閲覧。

google.ca

books.google.ca

Ravina, Enrique (2011). The evolution of drug discovery : from traditional medicines to modern drugs (1. Aufl. ed.). Weinheim: Wiley-VCH. p. 136. ISBN 9783527326693 Junghanss, Jeremy Farrar, Peter J. Hotez, Thomas (2013). Manson's tropical diseases. (23rd ed.). Oxford: Elsevier/Saunders. p. 569. ISBN 9780702053061

idsociety.org

“www.idsociety.org” (PDF). 2016年4月2日閲覧。 “Malaria - Chapter 3 - 2014 Yellow Book | Travelers' Health | CDC”. 2016年4月2日閲覧。

jcp.or.jp

“自衛隊員6人自殺海外派兵で抗マラリア薬投与抑うつ・不眠副作用の疑い小池議員への答弁書で判明”. www.jcp.or.jp. 日本共産党 (2007年8月16日). 2016年6月23日閲覧。

lci.fr

“"Malaria Business" ce soir sur France Ô : pourquoi le Lariam, un anti-paludique, qui a rendu malade Stromae, fait polémique” (html). La Chaîne Info. 2018年2月10日閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

Croft, AM (2007). “A lesson learnt: the rise and fall of Lariam and Halfan”. J R Soc Med. 4 (4): 170–4. doi:10.1258/jrsm.100.4.170. PMC 1847738. PMID 17404338.
Schlagenhauf, P; Adamcova, M; Regep, L; Schaerer, MT; Rhein, HG (2010-12-09). “The position of mefloquine as a 21st century malaria chemoprophylaxis”. Malaria journal 9: 357. doi:10.1186/1475-2875-9-357. PMC 3224336. PMID 21143906.
Schlagenhauf, P. (1999). “Mefloquine for malaria chemoprophylaxis 1992-1998”. Travel Med 6 (2): 122–123. doi:10.1111/j.1708-8305.1999.tb00843.x. PMID 10381965.
Jacquerioz, FA; Croft, AM (2009-10-07). Jacquerioz, Frederique A. ed. “Drugs for preventing malaria in travellers”. Cochrane database of systematic reviews (Online) (4): CD006491. doi:10.1002/14651858.CD006491.pub2. PMID 19821371.
González R, Hellgren U, Greenwood B, Menéndez C (2014). “Mefloquine safety and tolerability in pregnancy: a systematic literature review”. Malar. J. 13: 75. doi:10.1186/1475-2875-13-75. PMC 3942617. PMID 24581338.
Schlagenhauf P, Blumentals WA, Suter P, etal (2012). “Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy”. Clin Infect Dis 54 (11): e124–31. doi:10.1093/cid/cis215. PMC 3348951. PMID 22495078.
AlKadi, HO (2007). “Antimalarial drug toxicity: a review”. Chemotherapy 53 (6): 385-91. doi:10.1159/000109767. PMID 17934257.
Thomas KH (2014-09-30). “Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011.”. BMC Pharmacology and Toxicology 15 (54). doi:10.1186/2050-6511-15-54. PMC 4184159. PMID 25266008.
Bob Burton. (2004-11-06). “Australian army faces legal action over mefloquine.”. ブリティッシュ・メディカル・ジャーナル. (BMJ). 329 (7474): 1062. doi:10.1136/bmj.329.7474.1062-b. PMC 526142. PMID 15528599.
“Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study”. Clin. Infect. Dis. 33 (7): 1015–21. (October 2001). doi:10.1086/322694. PMID 11528574.
Gofton TE, Al-Khotani1 A, O'Farrell B, Ang LC, McLachlan RS (June 2010). “Mefloquine in the treatment of progressive multifocal leukoencephalopathy”. J Neurol Neurosurg Psychiatry 82 (4): 452–455. doi:10.1136/jnnp.2009.190652. PMID 20562463.
McArdle JJ, Sellin LC, Coakley KM, Potian JG, Quinones-Lopez MC, Rosenfeld CA, Sutatos LG, Hognason K (June 2005). “Mefloquine inhibits cholinesterases at the mouse neuromuscular junction”. Neuropharmacology 49 (8): 1132–1139. doi:10.1016/j.neuropharm.2005.06.011. PMID 16081111.
McArdle JJ, Sellin LC, Coakley KM, Potian JG, Hognason K (September 2006). “Mefloquine selectively increases asynchronous acetylcholine release from motor nerve terminals”. Neuropharmacology 50 (3): 345–353. doi:10.1016/j.neuropharm.2005.09.011. PMID 16288931.
Zhou C, Xiao C, McArdle JJ, Ye JH (February 2006). “Mefloquine enhances nigral gamma-aminobutyric acid release via inhibition of cholinesterase”. JPET 317 (3): 1155–1160. doi:10.1124/jpet.2005.106.101923. PMID 16501066.

pmc.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

Croft, AM (2007). “A lesson learnt: the rise and fall of Lariam and Halfan”. J R Soc Med. 4 (4): 170–4. doi:10.1258/jrsm.100.4.170. PMC 1847738. PMID 17404338.
Schlagenhauf, P; Adamcova, M; Regep, L; Schaerer, MT; Rhein, HG (2010-12-09). “The position of mefloquine as a 21st century malaria chemoprophylaxis”. Malaria journal 9: 357. doi:10.1186/1475-2875-9-357. PMC 3224336. PMID 21143906.
González R, Hellgren U, Greenwood B, Menéndez C (2014). “Mefloquine safety and tolerability in pregnancy: a systematic literature review”. Malar. J. 13: 75. doi:10.1186/1475-2875-13-75. PMC 3942617. PMID 24581338.
Schlagenhauf P, Blumentals WA, Suter P, etal (2012). “Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy”. Clin Infect Dis 54 (11): e124–31. doi:10.1093/cid/cis215. PMC 3348951. PMID 22495078.

pmda.go.jp

info.pmda.go.jp

“メファキン錠275 添付文書” (2013年2月). 2016年4月2日閲覧。

pri.org

Military Suicide Among Soldiers Who Haven't Deployed (2012-12-20) - en:Public Radio International (PRI)

rochecanada.com

“Lariam product monogram”. Hoffman La Roche Limited. p. 3. 2011年4月24日閲覧。
“Lariam product monogram”. Hoffman La Roche Limited. p. 4. 2011年4月24日閲覧。
“Lariam product monogram”. Hoffman La Roche Limited. p. 6. 2011年4月24日閲覧。
“Lariam product monogram”. Hoffman La Roche Limited. p. 18. 2011年4月24日閲覧。

sciencedirect.com

McArdle JJ, Sellin LC, Coakley KM, Potian JG, Quinones-Lopez MC, Rosenfeld CA, Sutatos LG, Hognason K (June 2005). “Mefloquine inhibits cholinesterases at the mouse neuromuscular junction”. Neuropharmacology 49 (8): 1132–1139. doi:10.1016/j.neuropharm.2005.06.011. PMID 16081111.
McArdle JJ, Sellin LC, Coakley KM, Potian JG, Hognason K (September 2006). “Mefloquine selectively increases asynchronous acetylcholine release from motor nerve terminals”. Neuropharmacology 50 (3): 345–353. doi:10.1016/j.neuropharm.2005.09.011. PMID 16288931.

theglobeandmail.com

Canadian military to reassess use of controversial anti-malaria drug (2016-11-15) - グローブ・アンド・メール

va.gov

publichealth.va.gov

ptsd.va.gov

William Hudenko, Beeta Homaifar, Hal Wortzel. “The Relationship Between PTSD and Suicide”. U.S. Department of Veterans Affairs (アメリカ合衆国退役軍人省). 2016年12月28日閲覧。

web.archive.org

“海外に派遣される自衛隊員への抗マラリア薬「塩酸メフロキン」予防投与の実態と副作用に関する質問に対する答弁書”. 防衛省、自衛隊 (2007年8月15日). 2016年10月21日閲覧。

who.int

apps.who.int

“WHO Model List of Essential Medicines” (PDF). World Health Organization (October 2013). 2014年4月22日閲覧。

メフロキン (Japanese Wikipedia)

aspetjournals.org

jpet.aspetjournals.org

biomedcentral.com

bmcpharmacoltoxicol.biomedcentral.com

bmj.com

bmj.com

jnnp.bmj.com

cdc.gov

wwwnc.cdc.gov

cdc.gov

doi.org

drugs.com

espacenet.com

worldwide.espacenet.com

fda.gov

accessdata.fda.gov

fda.gov

google.ca

books.google.ca

idsociety.org

jcp.or.jp

lci.fr

nih.gov

pubmed.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

pmda.go.jp

info.pmda.go.jp

pri.org

rochecanada.com

sciencedirect.com

theglobeandmail.com

va.gov

publichealth.va.gov

ptsd.va.gov

web.archive.org

who.int

apps.who.int

wikipedia.org

en.wikipedia.org